Is the US prepared to deal with another pandemic or widespread health crisis?
I’ll assess U.S. pandemic and health-crisis readiness by pulling recent official reports, expert analyses, and key metrics on stockpiles, surveillance, workforce, and funding.Gathering details from major recent assessments (GAO, Biodefense Commission, TFAH state rankings, Biden roadmap, WHO JEE, and stockpile status).The US is better prepared than it was before COVID-19 but is not fully ready for another major pandemic or widespread health crisis. Significant progress has been made in stockpiles, surveillance, coordination structures, and medical countermeasures, yet substantial gaps persist in funding sustainability, leadership/coordination, workforce, state/local capacities, public trust, and full implementation of lessons learned. Assessments from government watchdogs, bipartisan commissions, public health organizations, and international evaluations consistently describe a mixed picture: relative strength globally, but remaining vulnerabilities that could lead to preventable deaths, economic disruption, and strained systems in a severe event.[1]
Progress Since COVID-19
The Biden-Harris administration (and prior efforts) replenished and expanded key capabilities, documented in its January 2025 roadmap for pandemic preparedness:
A 2024 WHO Joint External Evaluation (JEE) of US International Health Regulations capacities (using a post-COVID tool) noted strong demonstrated capacities in many technical areas while issuing overarching recommendations.[5]
Persistent Gaps and Challenges
Multiple independent reviews highlight unfinished work:
Bottom Line and Outlook
The US has stronger tools—better stocked SNS, modernized data systems, dedicated offices, and MCM pipelines—than in early 2020, when it was ranked highly on paper yet struggled in practice due to execution, politics, and underinvestment. It can detect and respond faster to many threats and has demonstrated capability in smaller outbreaks (mpox, H5N1 containment efforts). However, experts across the spectrum (GAO, bipartisan commissions, TFAH, WHO JEE) agree it is not fully prepared for a severe, novel, or prolonged crisis involving high transmissibility, high severity, supply shocks, or concurrent events. Success depends on sustained (not boom-bust) funding, clearer leadership and authorities, closing SLTT gaps, rebuilding trust and workforce, domestic manufacturing resilience, and political will to implement remaining recommendations.[10]
Preparedness is dynamic. Ongoing threats like H5N1 avian influenza (with animal-to-human spillover) test current systems and underscore the need for vigilance. Reauthorizing key laws like PAHPA, fully addressing open GAO items, and maintaining investments would further close gaps. Globally, no country is perfectly ready, but the US’s relative strengths position it better than most—if lessons are fully applied.
Citations (10)
- https://www.gao.gov/products/gao-24-107175
Backs: “Assessments from government watchdogs, bipartisan commissions, public health organizations, and international evaluations consistently describe a mixed picture: relative strength globally, but remaining vulnerabilities that could lead to preventable deaths, economic disruption, and strained systems in a severe event.”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “The SNS has supported responses to H5N1 bird flu (PPE and antivirals), mpox (over 1 million JYNNEOS vaccine vials and tens of thousands of treatment courses), and other incidents. Domestic manufacturing contracts (e.g., hundreds of millions for gowns) aim to reduce supply-chain risks. Exact current inventories are not…”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “Surveillance and detection: Electronic case reporting expanded from fewer than 200 healthcare facilities pre-pandemic to over 45,000–48,000 by late 2024.”
- https://legalclarity.org/global-health-security-index-how-countries-are-ranked/
Backs: “Other gains: Largest domestic vaccination effort in history during COVID; free testing distribution; equity-focused outreach; community health workforce investments.”
- https://www.who.int/publications/i/item/9789240105409
Backs: “The US has historically ranked at or near the top of the Global Health Security Index (e.g., #1 with scores around 75–83 in recent editions), though no country scores perfectly and the index highlights univer”
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “The report issues 36 recommendations and 185 action items, emphasizing leadership (e.g., stronger National Security Advisor role for biodefense), a quadrennial strategy review, indoor air quality/pathogen transmission reduction, science/tech (Apollo-like program to end pandemics), intelligence, detection, and response.”
- https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/
Backs: “Weaknesses: 14 states cut public health funding in FY2024 (linked partly to expiring COVID funds); low flu vaccination (~47% vs. 70% goal); uneven paid sick leave; disparities in avoidable deaths (higher in Southeast/Appalachia and certain populations). All states have room to improve; federal PHEP funding and data…”
- https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/
Backs: “Funding and workforce: PHEMCE estimates large shortfalls (e.g., tens of billions over multi-year periods if appropriations stay flat). Public health workforce faces burnout, attrition, and recruitment issues despite temporary ARP investments.”
- https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “Other issues: Ambiguities in federal-state authorities; trust/communication challenges (exacerbated by polarization); incomplete learning of COVID lessons (e.g., NEJM commentary on H5N1 response risks); concurrent disasters straining resources (per National Preparedness Reports).”
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “However, experts across the spectrum (GAO, bipartisan commissions, TFAH, WHO JEE) agree it is not fully prepared for a severe, novel, or prolonged crisis involving high transmissibility, high severity, supply shocks, or concurrent events.”